Cargando…

Design of CGMP Production of (18)F- and (68)Ga-Radiopharmaceuticals

Objective. Radiopharmaceutical production process must adhere to current good manufacturing process (CGMP) compliance to ensure the quality of precursor, prodrug (active pharmaceutical ingredient, API), and the final drug product that meet acceptance criteria. We aimed to develop an automated system...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chi, Yen-Ting, Chu, Pei-Chun, Chao, Hao-Yu, Shieh, Wei-Chen, Chen, Chuck C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167646/ https://www.ncbi.nlm.nih.gov/pubmed/25276810 http://dx.doi.org/10.1155/2014/680195

Ejemplares similares

Corrigendum to “Design of CGMP Production of (18)F- and (68)Ga-Radiopharmaceuticals”
por: Chi, Yen-Ting, et al.
Publicado: (2016)

Prospective of (68)Ga-Radiopharmaceutical Development
por: Velikyan, Irina
Publicado: (2013)

Good practices for (68)Ga radiopharmaceutical production
por: Nelson, Bryce J. B., et al.
Publicado: (2022)

N-Benzylethanolammonium Ionic Liquids and Molten Salts in the Synthesis of (68)Ga- and Al(18)F-Labeled Radiopharmaceuticals
por: Kondratenko, Yulia A., et al.
Publicado: (2023)

[(68)Ga]Ga-DOTA-TOC: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging
por: Hennrich, Ute, et al.
Publicado: (2020)

(68)Ga-Based Radiopharmaceuticals: Production and Application Relationship
por: Velikyan, Irina
Publicado: (2015)

Cold Kit Labeling: The Future of (68)Ga Radiopharmaceuticals?
por: Lepareur, Nicolas
Publicado: (2022)

[(68)Ga]Ga-PSMA-11: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
por: Hennrich, Ute, et al.
Publicado: (2021)

New sensitive method for HEPES quantification in (68)Ga-radiopharmaceuticals
por: Antunes, I. F., et al.
Publicado: (2020)

Good practices for Ga-68 radiopharmaceutical production: an important correction
por: Gültekin, Aziz
Publicado: (2023)

Multifarious Ga-68 Labeled PET Radiopharmaceuticals in Imaging Various Malignancies
por: Vatsa, Rakhee, et al.
Publicado: (2018)

Instant kit preparation of (68)Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [(68)Ga]Ga-DATA-TOC
por: Sinnes, Jean-Philippe, et al.
Publicado: (2019)

Cyclotron Production of Gallium-68 Radiopharmaceuticals Using the (68)Zn(p,n)(68)Ga Reaction and Their Regulatory Aspects
por: Ashhar, Zarif, et al.
Publicado: (2022)

A Specific HPLC Method to Determine Residual HEPES in [(68)Ga]Ga-Radiopharmaceuticals: Development and Validation
por: Migliari, Silvia, et al.
Publicado: (2022)

Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG Uptake in Esophageal Cancer
por: Liu, Huipan, et al.
Publicado: (2022)

Preclinical evaluation of two (68)Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging
por: Petrik, Milos, et al.
Publicado: (2012)

Synthesis, Complexation Properties, and Evaluation of New Aminodiphosphonic Acids as Vector Molecules for (68)Ga Radiopharmaceuticals
por: Maruk, Alesya Ya., et al.
Publicado: (2021)

[(18)F]Tosyl fluoride as a versatile [(18)F]fluoride source for the preparation of (18)F-labeled radiopharmaceuticals
por: Zhou, Dong, et al.
Publicado: (2023)

A first-in-human study of [(68)Ga]Ga-CDI: a positron emitting radiopharmaceutical for imaging tumour cell death
por: Ho Shon, Ivan, et al.
Publicado: (2022)

Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [(68)Ga]Ga-ABY-025 tracer
por: Jussing, Emma, et al.
Publicado: (2023)

(68)Ga- or (18)F-FAPI PET/CT—what it can and cannot
por: Mori, Yuriko, et al.
Publicado: (2023)

Novel Preclinical and Radiopharmaceutical Aspects of [(68)Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
por: Eder, Matthias, et al.
Publicado: (2014)

Diagnostic value of [(68)Ga]Ga-FAPI-04 in patients with colorectal cancer in comparison with [(18)F]F-FDG PET/CT
por: Lin, Xinfeng, et al.
Publicado: (2023)

(68)Ga-FAPI-04 Versus (18)F-FDG PET/CT in the Detection of Hepatocellular Carcinoma
por: Wang, Hao, et al.
Publicado: (2021)

Performance evaluation of Cerenkov luminescence imaging: a comparison of (68)Ga with (18)F
por: olde Heuvel, J., et al.
Publicado: (2019)

Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG PET/MRI in the Preoperative Diagnosis of Gastric Cancer
por: Du, Tao, et al.
Publicado: (2023)

Development and comparison of (68)Ga/(18)F/(64)Cu-labeled nanobody tracers probing Claudin18.2
por: Wei, Weijun, et al.
Publicado: (2022)

A case of [(68)Ga]Ga-FAPI-46-avid and [(18)F]F-FDG-negative COVID-19 pneumonia sequelae
por: Telo, Silvi, et al.
Publicado: (2022)

Comparison of Diagnostic Efficacy of [(68)Ga]Ga-FAPI-04 and [(18)F]FDG PET/CT for Staging and Restaging of Gastric Cancer
por: Zhang, Shumao, et al.
Publicado: (2022)

The battle on time, money and precision: Da[(18)F] id vs. [(68)Ga]liath
por: Sahnoun, Sabri, et al.
Publicado: (2020)

A Case with (68)Ga-FAPI Positive and (18)F-FDG Negative Breast Cancer
por: Kömek, Halil, et al.
Publicado: (2021)

Comparison of (18)F-FDG PET/CT and (68)Ga-FAPI in Spindle Cell Rhabdomyosarcoma
por: Shen, Zhihui, et al.
Publicado: (2023)

Quantitative Analysis and Comparison Study of [(18)F]AlF-NOTA-PRGD2, [(18)F]FPPRGD2 and [(68)Ga]Ga-NOTA-PRGD2 Using a Reference Tissue Model
por: Guo, Ning, et al.
Publicado: (2012)

Evaluation of (18)F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with (68)Ga-DOTATATE PET/CT
por: Hou, Jiale, et al.
Publicado: (2021)

Good practices for the automated production of (18)F-SiFA radiopharmaceuticals
por: Blok, Simon, et al.
Publicado: (2023)

Diagnostic Performance of [(18)F]Fluorocholine and [(68)Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study
por: Paymani, Zeinab, et al.
Publicado: (2020)

Comparison between [(68)Ga]Ga-PSMA-617 and [(18)F]FET PET as Imaging Biomarkers in Adult Recurrent Glioblastoma
por: Brighi, Caterina, et al.
Publicado: (2023)

Preparation and Evaluation of [(18)F]AlF-NOTA-NOC for PET Imaging of Neuroendocrine Tumors: Comparison to [(68)Ga]Ga-DOTA/NOTA-NOC
por: Dam, Johan Hygum, et al.
Publicado: (2022)

Prospective comparison of [(18)F]AlF-NOTA-octreotide PET/MRI to [(68)Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients
por: Boeckxstaens, Lennert, et al.
Publicado: (2023)

(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity
por: Chang, Chian A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a5hd2teqvebv9h6istodql2gn7